InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Anand Bhaskar, Vice-Président, Responsable de la Comptabilité. Officer active across 2 companies, notably Reata Pharmaceuticals INC. Aggregated, 12 filings have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €250k. Activity tracked since 3 January 2022. The latest transaction was disclosed on 21 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Anand Bhaskar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
26,680 股@ US$18.7448.7% 占其流量Common StockSEC:0001890784-25-000005:0
22,026 股@ US$22.70100.0% 占其流量Common StockSEC:0001599298-24-000135:0
24,089 股Class A common stockSEC:0000899243-23-019532:0
406 股@ US$169.2022.1% 占其流量Class A common stockSEC:0001209191-23-048601:0
193 股@ US$169.05510.3% 占其流量Class A common stockSEC:0001209191-23-046276:0
1,562 股@ US$27.3213.6% 占其流量Class A common stockSEC:0001209191-23-037802:0
950 股@ US$85.983326.0% 占其流量Class A common stockSEC:0001209191-23-030181:0
165 股@ US$84.584.5% 占其流量Class A common stockSEC:0001209191-23-017248:0
820 股@ US$87.4723.4% 占其流量Class A common stockSEC:0001209191-23-016281:0
3,000 股0Class A common stockSEC:0001209191-23-014817:0
8,250 股0Class A common stockSEC:0001209191-23-000851:0
12,500 股0Class A common stockSEC:0001209191-22-001640:0
12 条申报中的 12 条
About Anand Bhaskar
Anand Bhaskar is Vice President, Responsible for Accounting. He has 12 filings in total, and across the 12 sampled filings between 2022-01-05 and 2025-10-23, sales total 249812 EUR and the most frequent transaction nature is Attribution. His filings concern Reata Pharmaceuticals INC and Summit Therapeutics Inc.
